查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1651980

癌症/腫瘤分析的全球市場:市場規模·佔有率·趨勢，產業分析 (癌症類別·各技術·手法·各用途·各地區)，未來預測 (2025年～2034年)

Cancer or Tumor Profiling Market Size, Share, Trends, Industry Analysis Report: By Cancer Type, Technology, Technique, Application, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的一項新研究，全球癌症/腫瘤分析市場預計到 2034 年將達到 353.6 億美元。該研究報告對當前市場動態提供了詳細的見解，並對未來市場成長進行了分析。

癌症/腫瘤分析市場的擴張受到全球癌症發生率上升和個人化醫療需求成長的推動。關鍵推動因素包括基因組技術的進步，例如下一代定序（NGS）和液體活檢，這些技術可以實現更早的檢測、更好的診斷和更有針對性的治療。癌症/腫瘤分析的市場機會存在於新興市場，這些市場中醫療保健機會和認知度的提高推動著癌症分析技術的採用。

人工智慧（AI）融入數據分析以及對非侵入性診斷方法的日益關注等趨勢正在塑造市場。由於人們更加重視透過個人化和更​​有效的治療策略來改善患者的治療效果，預計生物標記發現的持續創新和精準診斷的監管支持將推動市場持續擴張。

癌症/腫瘤分析市場：分析概述

由於乳癌發生率高且對個人化治療和基因組分析的需求不斷增長，乳癌佔據癌症/腫瘤分析市場的最大佔有率。然而，由於液體活檢和先進的基因組分析在早期檢測和針對性治療的應用越來越多，因此預計肺癌領域將實現最高成長。

基於技術，次世代定序 (NGS) 領域佔據市場主導地位，為腫瘤的基因特徵提供全面的見解並推動精準腫瘤學的發展。聚合酶鍊式反應（PCR）領域是成長最快的技術領域，得益於其成本效益以及在早期癌症檢測液體活檢中的應用。

根據方法論，基因組學領域在癌症/腫瘤分析市場收入佔有率中處於領先地位，因為它能夠提供有關突變、基因表現和腫瘤異質性的深入分子數據，這對於個人化醫療至關重要。表觀遺傳學領域因其在闡明驅動癌症進展和治療反應的分子機制方面發揮的作用而正在經歷最快的增長。

基於應用，個人化醫療領域佔據市場主導地位。越來越多的腫瘤學家採用基於基因組和生物標記的檢測來指導治療決策並改善患者的治療效果。隨著用於早期檢測和監測癌症進展的新的、更精確的生物標記不斷被發現，生物標記發現領域正在迅速發展。

由於北美擁有先進的醫療基礎設施以及對精準腫瘤學的濃厚興趣，預計其將佔據最大的市場佔有率。由於醫療保健機會的增加、癌症發病率的上升以及癌症分析技術的日益普及，亞太地區成為成長最快的市場。

目錄

第1章 簡介

第2章 摘要整理

第3章 分析方法

第4章 癌症/腫瘤分析市場洞察

  • 市場概述
  • 癌症/腫瘤分析市場動態
    • 推動因素和機遇
      • 將液體切片融入診斷
      • 新一代定序 (NGS) 的作用不斷擴大
    • 阻礙因素和課題
      • 分析技術成本高
  • 大環境分析
  • 全球癌症/腫瘤分析市場趨勢
  • 價值鏈分析
  • COVID-19影響分析

第5章 全球癌症/腫瘤分析市場:癌症類別

  • 主要的分析結果
  • 簡介
  • 乳癌
  • 肺癌症
  • 大腸癌症
  • 前列腺癌症
  • 黑色素瘤癌症
  • 其他

第6章 全球癌症/腫瘤分析市場:各技術

  • 主要的分析結果
  • 簡介
  • 次世代定序 (NGS)
  • 聚合酵素鏈鎖反應 (PCR)
  • 免疫組織化學 (IHC)
  • 界內犀牛親嘴雜合反應 (ISH)
  • 微陣列
  • 其他

第7章 全球癌症/腫瘤分析市場:手法

  • 主要的分析結果
  • 簡介
  • 基因學
  • 蛋白質體學
  • 表觀遺傳學
  • 代謝體學

第8章 全球癌症/腫瘤分析市場:各用途

  • 主要的分析結果
  • 簡介
  • 個人化醫療
  • 診斷
  • 生物標誌物的發現
  • 預測
  • 其他

第9章 全球癌症/腫瘤分析市場:各地區

  • 主要的分析結果
  • 簡介
    • 全球癌症/腫瘤分析市場評估:各地區 (2020～2034年)
  • 北美
    • 北美:癌症類別 (2020～2034年)
    • 北美:各技術 (2020～2034年)
    • 北美:手法 (2020～2034年)
    • 北美:各用途 (2020～2034年)
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:癌症類別 (2020～2034年)
    • 歐洲:各技術 (2020～2034年)
    • 歐洲:手法 (2020～2034年)
    • 歐洲:各用途 (2020～2034年)
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:癌症類別 (2020～2034年)
    • 亞太地區:各技術 (2020～2034年)
    • 亞太地區:手法 (2020～2034年)
    • 亞太地區:各用途 (2020～2034年)
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:癌症類別 (2020～2034年)
    • 中東·非洲:各技術 (2020～2034年)
    • 中東·非洲:手法 (2020～2034年)
    • 中東·非洲:各用途 (2020～2034年)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東·非洲
  • 南美
    • 南美:癌症類別 (2020～2034年)
    • 南美:各技術 (2020～2034年)
    • 南美:手法 (2020～2034年)
    • 南美:各用途 (2020～2034年)
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第10章 競爭情形

  • 事業擴大·企業收購的分析
    • 事業擴大
    • 企業收購
  • 聯盟/合作/協定/公開

第11章 企業簡介

  • Illumina
  • Thermo Fisher Scientific
  • Qiagen
  • F. Hoffmann-La Roche
  • Agilent Technologies
  • Bio-Rad Laboratories
  • PerkinElmer
  • Foundation Medicine (a Roche subsidiary)
  • Guardant Health
  • NeoGenomics Laboratories
  • Pacific Biosciences
  • Personalis
  • GRAIL (a subsidiary of Illumina)
  • Invitae
  • Genomic Health (a subsidiary of Exact Sciences)
Product Code: PM1713

The global cancer or tumor profiling market size is expected to reach USD 35.36 billion by 2034, according to a new study by Polaris Market Research. The report "Cancer or Tumor Profiling Market Size, Share, Trends, Industry Analysis Report: By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, and Others), Technology, Technique, Application, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The cancer or tumor profiling market expansion is driven by the increasing prevalence of cancer worldwide and the growing demand for personalized medicine. Key drivers include advancements in genomic technologies such as next-generation sequencing (NGS) and liquid biopsy, which enable early detection, better diagnosis, and more targeted treatments. Cancer or tumor profiling market opportunities exist in emerging markets, where rising healthcare access and awareness are boosting the adoption of cancer profiling technologies.

Trends such as the integration of artificial intelligence (AI) for data analysis and the growing focus on noninvasive diagnostic techniques are shaping the market. With ongoing innovations in biomarker discovery and regulatory support for precision diagnostics, the market is poised for continued expansion, with a heightened emphasis on improving patient outcomes through personalized and more effective treatment strategies.

Cancer or Tumor Profiling Market Report Highlights

The breast cancer segment, by cancer type, holds the largest cancer or tumor profiling market share due to its high prevalence and the growing demand for personalized treatments and genomic profiling. However, the lung cancer segment is registering the highest growth due to the increasing use of liquid biopsy and advanced genomic profiling for early detection and targeted therapies.

By technology, the next-generation sequencing (NGS) segment dominates the market, offering comprehensive insights into tumor genetic profiles and driving precision oncology. The polymerase chain reaction (PCR) segment is the fastest-growing technology segment, fueled by its cost-effectiveness and application in liquid biopsy for early cancer detection.

The genomics segment, based on technique, leads the cancer or tumor profiling market revenue share due to its ability to provide in-depth molecular data on mutations, gene expressions, and tumor heterogeneity, which are critical for personalized medicine. The epigenetics segment is experiencing the highest growth, driven by its role in uncovering molecular mechanisms that drive cancer progression and response to treatment.

In terms of application, the personalized medicine segment dominates the market, as more oncologists adopt genomic and biomarker-based testing to guide treatment decisions and improve patient outcomes. The biomarker discovery segment is growing rapidly as new and more precise biomarkers are being identified for early detection and monitoring of cancer progression.

North America holds the largest market share, supported by its advanced healthcare infrastructure and strong focus on precision oncology. Asia Pacific is the fastest-growing market, driven by increasing healthcare access, rising cancer rates, and expanding adoption of cancer profiling technologies.

Polaris Market Research has segmented the cancer or tumor profiling market report on the basis of cancer type, technology, technique, application, and region:

By Cancer Type Outlook (Revenue - USD Billion, 2020-2034)

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Melanoma Cancer
  • Others

By Technology Outlook (Revenue - USD Billion, 2020-2034)

  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Immunohistochemistry (IHC)
  • In-Situ Hybridization (ISH)
  • Microarray
  • Others

By Technique Outlook (Revenue - USD Billion, 2020-2034)

  • Genomics
  • Proteomics
  • Epigenetics
  • Metabolomics

By Application Outlook (Revenue - USD Billion, 2020-2034)

  • Personalized Medicine
  • Diagnostics
  • Biomarker Discovery
  • Prognostics
  • Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Cancer or Tumour Profiling Market Insights

  • 4.1. Global Cancer or Tumour Profiling Market - Market Snapshot
  • 4.2. Global Cancer or Tumour Profiling Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Integration of Liquid Biopsy in Diagnostics
      • 4.2.1.2. Growing Role of Next-Generation Sequencing (NGS)
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost of Profiling Technologies
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Global Cancer or Tumour Profiling Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Cancer or Tumour Profiling Market, by Cancer Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • 5.3. Breast Cancer
    • 5.3.1. Global Cancer or Tumour Profiling Market, by Breast Cancer, by Region, 2020-2034 (USD Billion)
  • 5.4. Lung Cancer
    • 5.4.1. Global Cancer or Tumour Profiling Market, by Lung Cancer, by Region, 2020-2034 (USD Billion)
  • 5.5. Colorectal Cancer
    • 5.5.1. Global Cancer or Tumour Profiling Market, by Colorectal Cancer, by Region, 2020-2034 (USD Billion)
  • 5.6. Prostate Cancer
    • 5.6.1. Global Cancer or Tumour Profiling Market, by Prostate Cancer, by Region, 2020-2034 (USD Billion)
  • 5.7. Melanoma Cancer
    • 5.7.1. Global Cancer or Tumour Profiling Market, by Melanoma Cancer, by Region, 2020-2034 (USD Billion)
  • 5.8. Others
    • 5.8.1. Global Cancer or Tumour Profiling Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Cancer or Tumour Profiling Market, by Technology

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • 6.3. Next-Generation Sequencing (NGS)
    • 6.3.1. Global Cancer or Tumour Profiling Market, by Next-Generation Sequencing (NGS), by Region, 2020-2034 (USD Billion)
  • 6.4. Polymerase Chain Reaction (PCR)
    • 6.4.1. Global Cancer or Tumour Profiling Market, by Bakery & Confectionary, by Region, 2020-2034 (USD Billion)
  • 6.5. Immunohistochemistry (IHC)
    • 6.5.1. Global Cancer or Tumour Profiling Market, by Immunohistochemistry (IHC), by Region, 2020-2034 (USD Billion)
  • 6.6. In-Situ Hybridization (ISH)
    • 6.6.1. Global Cancer or Tumour Profiling Market, by In-Situ Hybridization (ISH), by Region, 2020-2034 (USD Billion)
  • 6.7. Microarray
    • 6.7.1. Global Cancer or Tumour Profiling Market, by Microarray, by Region, 2020-2034 (USD Billion)
  • 6.8. Others
    • 6.8.1. Global Cancer or Tumour Profiling Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Cancer or Tumour Profiling Market, by Technique

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • 7.3. Genomics
    • 7.3.1. Global Cancer or Tumour Profiling Market, by Genomics, by Region, 2020-2034 (USD Billion)
  • 7.4. Proteomics
    • 7.4.1. Global Cancer or Tumour Profiling Market, by Proteomics, by Region, 2020-2034 (USD Billion)
  • 7.5. Epigenetics
    • 7.5.1. Global Cancer or Tumour Profiling Market, by Epigenetics, by Region, 2020-2034 (USD Billion)
  • 7.6. Metabolomics
    • 7.6.1. Global Cancer or Tumour Profiling Market, by Metabolomics, by Region, 2020-2034 (USD Billion)

8. Global Cancer or Tumour Profiling Market, by Application

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • 8.3. Personalized Medicine
    • 8.3.1. Global Cancer or Tumour Profiling Market, by Personalized Medicine, by Region, 2020-2034 (USD Billion)
  • 8.4. Diagnostics
    • 8.4.1. Global Cancer or Tumour Profiling Market, by Diagnostics, by Region, 2020-2034 (USD Billion)
  • 8.5. Biomarker Discovery
    • 8.5.1. Global Cancer or Tumour Profiling Market, by Biomarker Discovery, by Region, 2020-2034 (USD Billion)
  • 8.6. Prognostics
    • 8.6.1. Global Cancer or Tumour Profiling Market, by Prognostics, by Region, 2020-2034 (USD Billion)
  • 8.7. Others
    • 8.7.1. Global Cancer or Tumour Profiling Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global Cancer or Tumour Profiling Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Cancer or Tumour Profiling Market Assessment, By Geography, 2020-2034 (USD billion)
  • 9.3. Global Cancer or Tumour Profiling Market - North America
    • 9.3.1. North America: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
    • 9.3.2. North America: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
    • 9.3.3. North America: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
    • 9.3.4. North America: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.3.5. Global Cancer or Tumour Profiling Market - US
      • 9.3.5.1. US: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.3.5.2. US: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.3.5.3. US: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.3.5.4. US: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.3.6. Global Cancer or Tumour Profiling Market - Canada
      • 9.3.6.1. Canada: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.3.6.2. Canada: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.3.6.3. Canada: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.3.6.4. Canada: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • 9.4. Global Cancer or Tumour Profiling Market - Europe
    • 9.4.1. Europe: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
    • 9.4.2. Europe: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
    • 9.4.3. Europe: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
    • 9.4.4. Europe: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.4.5. Global Cancer or Tumour Profiling Market - UK
      • 9.4.5.1. UK: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.4.5.2. UK: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.4.5.3. UK: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.4.5.4. UK: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.4.6. Global Cancer or Tumour Profiling Market - France
      • 9.4.6.1. France: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.4.6.2. France: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.4.6.3. France: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.4.6.4. France: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.4.7. Global Cancer or Tumour Profiling Market - Germany
      • 9.4.7.1. Germany: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.4.7.2. Germany: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.4.7.3. Germany: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.4.7.4. Germany: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.4.8. Global Cancer or Tumour Profiling Market - Italy
      • 9.4.8.1. Italy: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.4.8.2. Italy: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.4.8.3. Italy: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.4.8.4. Italy: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.4.9. Global Cancer or Tumour Profiling Market - Spain
      • 9.4.9.1. Spain: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.4.9.2. Spain: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.4.9.3. Spain: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.4.9.4. Spain: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.4.10. Global Cancer or Tumour Profiling Market - Netherlands
      • 9.4.10.1. Netherlands: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.4.10.2. Netherlands: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.4.10.3. Netherlands: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.4.10.4. Netherlands: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.4.11. Global Cancer or Tumour Profiling Market - Russia
      • 9.4.11.1. Russia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.4.11.2. Russia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.4.11.3. Russia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.4.11.4. Russia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.4.12. Global Cancer or Tumour Profiling Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.4.12.2. Rest of Europe: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.4.12.3. Rest of Europe: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.4.12.4. Rest of Europe: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • 9.5. Global Cancer or Tumour Profiling Market - Asia Pacific
    • 9.5.1. Asia Pacific: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
    • 9.5.2. Asia Pacific: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
    • 9.5.3. Asia Pacific: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
    • 9.5.4. Asia Pacific: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.5.5. Global Cancer or Tumour Profiling Market - China
      • 9.5.5.1. China: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.5.5.2. China: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.5.5.3. China: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.5.5.4. China: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.5.6. Global Cancer or Tumour Profiling Market - India
      • 9.5.6.1. India: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.5.6.2. India: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.5.6.3. India: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.5.6.4. India: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.5.7. Global Cancer or Tumour Profiling Market - Malaysia
      • 9.5.7.1. Malaysia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.5.7.2. Malaysia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.5.7.3. Malaysia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.5.7.4. Malaysia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.5.8. Global Cancer or Tumour Profiling Market - Japan
      • 9.5.8.1. Japan: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.5.8.2. Japan: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.5.8.3. Japan: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.5.8.4. Japan: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.5.9. Global Cancer or Tumour Profiling Market - Indonesia
      • 9.5.9.1. Indonesia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.5.9.2. Indonesia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.5.9.3. Indonesia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.5.9.4. Indonesia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.5.10. Global Cancer or Tumour Profiling Market - South Korea
      • 9.5.10.1. South Korea: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.5.10.2. South Korea: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.5.10.3. South Korea: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.5.10.4. South Korea: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.5.11. Global Cancer or Tumour Profiling Market - Australia
      • 9.5.11.1. Australia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.5.11.2. Australia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.5.11.3. Australia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.5.11.4. Australia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.5.12. Global Cancer or Tumour Profiling Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.5.12.2. Rest of Asia Pacific: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.5.12.3. Rest of Asia Pacific: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.5.12.4. Rest of Asia Pacific: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • 9.6. Global Cancer or Tumour Profiling Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
    • 9.6.2. Middle East & Africa: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
    • 9.6.3. Middle East & Africa: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
    • 9.6.4. Middle East & Africa: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.6.5. Global Cancer or Tumour Profiling Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.6.5.2. Saudi Arabia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.6.5.3. Saudi Arabia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.6.5.4. Saudi Arabia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.6.6. Global Cancer or Tumour Profiling Market - UAE
      • 9.6.6.1. UAE: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.6.6.2. UAE: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.6.6.3. UAE: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.6.6.4. UAE: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.6.7. Global Cancer or Tumour Profiling Market - Israel
      • 9.6.7.1. Israel: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.6.7.2. Israel: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.6.7.3. Israel: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.6.7.4. Israel: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.6.8. Global Cancer or Tumour Profiling Market - South Africa
      • 9.6.8.1. South Africa: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.6.8.2. South Africa: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.6.8.3. South Africa: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.6.8.4. South Africa: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.6.9. Global Cancer or Tumour Profiling Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.6.9.2. Rest of Middle East & Africa: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.6.9.3. Rest of Middle East & Africa: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.6.9.4. Rest of Middle East & Africa: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • 9.7. Global Cancer or Tumour Profiling Market - Latin America
    • 9.7.1. Latin America: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
    • 9.7.2. Latin America: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
    • 9.7.3. Latin America: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
    • 9.7.4. Latin America: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.7.5. Global Cancer or Tumour Profiling Market - Mexico
      • 9.7.5.1. Mexico: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.7.5.2. Mexico: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.7.5.3. Mexico: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.7.5.4. Mexico: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.7.6. Global Cancer or Tumour Profiling Market - Brazil
      • 9.7.6.1. Brazil: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.7.6.2. Brazil: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.7.6.3. Brazil: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.7.6.4. Brazil: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.7.7. Global Cancer or Tumour Profiling Market - Argentina
      • 9.7.7.1. Argentina: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.7.7.2. Argentina: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.7.7.3. Argentina: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.7.7.4. Argentina: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.7.8. Global Cancer or Tumour Profiling Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.7.8.2. Rest of Latin America: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.7.8.3. Rest of Latin America: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.7.8.4. Rest of Latin America: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Illumina
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Thermo Fisher Scientific
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Qiagen
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. F. Hoffmann-La Roche
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Agilent Technologies
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Bio-Rad Laboratories
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. PerkinElmer
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Foundation Medicine (a Roche subsidiary)
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Guardant Health
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. NeoGenomics Laboratories
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Pacific Biosciences
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Personalis
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. GRAIL (a subsidiary of Illumina)
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Invitae
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
  • 11.15. Genomic Health (a subsidiary of Exact Sciences)
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Benchmarking
    • 11.15.4. Recent Development

List of Tables:

  • Table 1 Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 2 Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 3 Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 4 Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 5 North America: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 6 North America: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 7 North America: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 8 North America: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 9 US: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 10 US: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 11 US: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 12 US: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 13 Canada: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 14 Canada: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 15 Canada: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 16 Canada: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 17 Europe: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 18 Europe: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 19 Europe: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 20 Europe: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 21 UK: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 22 UK: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 23 UK: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 24 UK: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 25 France: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 26 France: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 27 France: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 28 France: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 29 Germany: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 30 Germany: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 31 Germany: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 32 Germany: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 33 Italy: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 34 Italy: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 35 Italy: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 36 Italy: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 37 Spain: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 38 Spain: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 39 Spain: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 40 Spain: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 41 Netherlands: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 42 Netherlands: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 43 Netherlands: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 44 Netherlands: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 45 Russia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 46 Russia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 47 Russia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 48 Russia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 49 Rest of Europe: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 50 Rest of Europe: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 51 Rest of Europe: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 52 Rest of Europe: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 53 Asia Pacific: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 54 Asia Pacific: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 55 Asia Pacific: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 56 Asia Pacific: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 57 China: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 58 China: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 59 China: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 60 China: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 61 India: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 62 India: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 63 India: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 64 India: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 65 Malaysia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 66 Malaysia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 67 Malaysia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 68 Malaysia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 69 Japan: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 70 Japan: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 71 Japan: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 72 Japan: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 73 Indonesia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 74 Indonesia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 75 Indonesia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 76 Indonesia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 77 South Korea: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 78 South Korea: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 79 South Korea: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 80 South Korea: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 81 Australia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 82 Australia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 83 Australia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 84 Australia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 85 Rest of Asia Pacific: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 86 Rest of Asia Pacific: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 87 Rest of Asia Pacific: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 88 Rest of Asia Pacific: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 89 Middle East & Africa: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 90 Middle East & Africa: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 91 Middle East & Africa: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 92 Middle East & Africa: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 93 Saudi Arabia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 94 Saudi Arabia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 95 Saudi Arabia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 96 Saudi Arabia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 97 UAE: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 98 UAE: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 99 UAE: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 100 UAE: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 101 Israel: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 102 Israel: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 103 Israel: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 104 Israel: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 105 South Africa: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 106 South Africa: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 107 South Africa: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 108 South Africa: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 109 Rest of Middle East & Africa: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 110 Rest of Middle East & Africa: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 111 Rest of Middle East & Africa: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 112 Rest of Middle East & Africa: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 113 Latin America: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 114 Latin America: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 115 Latin America: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 116 Latin America: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 117 Mexico: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 118 Mexico: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 119 Mexico: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 120 Mexico: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 121 Brazil: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 122 Brazil: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 123 Brazil: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 124 Brazil: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 125 Argentina: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 126 Argentina: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 127 Argentina: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 128 Argentina: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 129 Rest of Latin America: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 130 Rest of Latin America: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 131 Rest of Latin America: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 132 Rest of Latin America: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)

List of Figures:

  • Figure 1. Global Cancer or Tumour Profiling Market, 2020-2034 (USD billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Cancer Type
  • Figure 7. Global Cancer or Tumour Profiling Market, by Cancer Type, 2024 & 2034 (USD billion)
  • Figure 8. Market by Technology
  • Figure 9. Global Cancer or Tumour Profiling Market, by Technology, 2024 & 2034 (USD billion)
  • Figure 10. Market by Technique
  • Figure 11. Global Cancer or Tumour Profiling Market, by Technique, 2024 & 2034 (USD billion)
  • Figure 12. Market by Application
  • Figure 13. Global Cancer or Tumour Profiling Market, by Application, 2024 & 2034 (USD billion)
  • Figure 14. Global Cancer or Tumour Profiling Market Assessment, By Geography, 2020-2034 (USD billion)
  • Figure 15. Strategic Analysis - Global Cancer or Tumour Profiling Market